3Z
Latest round
- Seed
Last raised
- Oct 2020
Total raised
- $0.6M
Investors
- 3
About 3Z
a. 3Z Pharmaceuticals develops repurposed small molecule drugs that target neurological indications based on its zebrafish screening technology. In June 2022, 3Z Ltd. The company product pipeline includes novel ADHD therapeutics, such as 3Z-20-001, 3Z-20-002, 3Z-20-003, and 3Z-20-004 used to treat neurological disorders, enabling patients to get multiple drug efficacy and toxicity assays. 3Z Pharmaceuticals has utilized its zebrafish screening platform to identify novel and repurposed therapeutics candidates for insomnia and ADHD. Insomnia therapeutics encompasses a novel mechanism of action that may combat insomnia and metabolic syndrome, indications with significant comorbidity. The novel ADHD therapeutics are all non-stimulants, poised to fill a gap in the market, with fewer side effects compared to contemporary treatments, and offer an alternative for non-responders.
Who invested in 3Z
3 investors across 3 rounds
See all investors in 3Z
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about 3Z
Who invested in 3Z?
3Z has 3 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has 3Z raised?
3Z has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did 3Z last raise money?
3Z's most recent round on record is a Seed, in Oct 2020.
What does 3Z do?
3Z is a biotechnology company.
Where is 3Z headquartered?
3Z is headquartered in Reykjavík, Iceland.
Which VCs invest in companies like 3Z?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at 3Z's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like 3Z? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.